The corticobasal degeneration syndrome overlaps progressive aphasia and frontotemporal dementia

被引:215
作者
Kertesz, A [1 ]
Martinez-Lage, P
Davidson, W
Munoz, DG
机构
[1] Univ Western Ontario, St Josephs Hosp, Dept Clin Neurol Sci, London, ON N6A 4V2, Canada
[2] Univ Western Ontario, St Josephs Hosp, Dept Pathol, London, ON N6A 4V2, Canada
[3] Hosp Univ Doce Octubre, Neurol Serv, Madrid, Spain
[4] Geriatr & Day Care Ctr Landazabal, Alzheimer Program, Pamplona, Spain
关键词
D O I
10.1212/WNL.55.9.1368
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: To provide evidence for the hypothesis that the corticobasal degeneration syndrome (CBDs) overlaps significantly with primary progressive aphasia and frontotemporal dementia, and that CBDs is part of the Pick complex. Background: Corticobasal degeneration has been mainly described as a movement disorder, but cognitive impairment is also increasingly noted. Methods: Thirty-five cases of clinically diagnosed CBDs were followed-up with clinical, neuropsychological, and neuroimaging investigations. Twenty-nine patients were seen prospectively in movement disorder and cognitive neurology clinics; five of these came to autopsy. Six other autopsied cases that fulfilled the clinical criteria of CBDs were added with retrospective review of records. Results: All 15 patients presenting with movement disorders developed behavioral, cognitive, or language deficits shortly after onset or after several years. Patients presenting with cognitive problems (n = 20), progressive aphasia (n = 13), or frontotemporal dementia (n = 7) developed the movement disorder subsequently. Eleven cases with autopsy had CBD or other forms of the Pick complex. Conclusions: There is a clinical overlap between CBD, frontotemporal dementia, and primary progressive aphasia. There is also a pathologic overlap between these clinical syndromes. The recognition of this overlap will facilitate the diagnosis and avoid consideration of CBD as 'heterogenous".
引用
收藏
页码:1368 / 1375
页数:22
相关论文
共 43 条
  • [21] Clinical presentation and pharmacological therapy in corticobasal degeneration
    Kompoliti, K
    Goetz, CG
    Boeve, BF
    Maraganore, DM
    Ahlskog, JE
    Marsden, CD
    Bhatia, KP
    Greene, PE
    Przedborski, S
    Seal, EC
    Burns, RS
    Hauser, RA
    Gauger, LL
    Factor, SA
    Molho, ES
    Riley, DE
    [J]. ARCHIVES OF NEUROLOGY, 1998, 55 (07) : 957 - 961
  • [22] LANG AE, 1992, J NEUROL NEUROSUR PS, V55, P1101, DOI 10.1136/jnnp.55.11.1101
  • [23] THE NATURE OF APRAXIA IN CORTICOBASAL DEGENERATION
    LEIGUARDA, R
    LEES, AJ
    MERELLO, M
    STARKSTEIN, S
    MARSDEN, CD
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1994, 57 (04) : 455 - 459
  • [24] PRIMARY PROGRESSIVE APHASIA WITH FOCAL NEURONAL ACHROMASIA
    LIPPA, CF
    COHEN, R
    SMITH, TW
    DRACHMAN, DA
    [J]. NEUROLOGY, 1991, 41 (06) : 882 - 886
  • [25] Litvan I, 1999, J NEUROL, V246, P1
  • [26] Accuracy of the clinical diagnosis of corticobasal degeneration: A clinicopathologic study
    Litvan, I
    Agid, Y
    Goetz, C
    Jankovic, J
    Wenning, GK
    Brandel, JP
    Lai, EC
    Verny, M
    RayChaudhuri, K
    McKee, A
    Jellinger, K
    Pearce, RKB
    Bartko, JJ
    [J]. NEUROLOGY, 1997, 48 (01) : 119 - 125
  • [27] Marti Masso J F, 1994, Neurologia, V9, P115
  • [28] Apraxia differs in corticobasal degeneration and left-parietal stroke: A case study
    Merians, AS
    Clark, M
    Poizner, H
    Jacobs, DH
    Adair, JC
    Macauley, B
    Rothi, LJG
    Heilman, KM
    [J]. BRAIN AND COGNITION, 1999, 40 (02) : 314 - 335
  • [29] PRIMARY PROGRESSIVE APHASIA - DIFFERENTIATION FROM ALZHEIMERS-DISEASE
    MESULAM, MM
    [J]. ANNALS OF NEUROLOGY, 1987, 22 (04) : 533 - 534
  • [30] MORLAAS J, 1928, CONTRIBUTION ETUDE A